Study: Older adults receiving high-quality care more likely to get shingles vaccine
By
John Roszkowski
Sep 25, 2023
Elderly patients who receive high-quality primary care are more likely to get the shingles vaccine upon a doctor’s recommendation, according to a new Japanese study.
Shingles associated with increased risk for stroke, heart attack
By
Alicia Lasek
Dec 01, 2022
Shingles, a disease found mainly among older adults, is tied to 30% long-term odds of major cardiovascular events such as heart attack and stroke, a new study finds.
Shingrix shingles vaccine protects seniors for 10 years, new data show
By
Alicia Lasek
Oct 20, 2022
Older adults have long-term protection against shingles after receiving Shingrix, which has demonstrated 80% efficacy in ongoing clinical trials, the drug’s maker reports.
More seniors getting flu, shingles and pneumonia shots, but disparities remain
By
Alicia Lasek
Sep 30, 2022
Vaccination discrepancies among older demographic groups are likely due to care access, hesitancy and cost, the AARP says.
COVID-19 linked to increased risk of shingles, pharma company finds
By
Alicia Lasek
Apr 11, 2022
Older adults with a COVID-19 diagnosis are 15% more likely to develop shingles than their peers who have never been diagnosed with the disease, a study supported by vaccine-maker GlaxoSmithKline has found.
Can mRNA tech make a better shingles shot? Vaccine makers plan to find out
By
Alicia Lasek
Jan 06, 2022
Pfizer and BioNTech plan to speed development of a prospective shingles drug, with clinical trials expected to begin in the second half of 2022.
Shingles vaccine awareness may prevent flu shot avoidance next year, docs say
By
Alicia Lasek
Nov 22, 2021
Shingles vaccine side effects are nothing to sneeze at, a new study suggests. They may be the reason that older adults who receive flu and shingles shots on the same day are less likely to get a flu shot...
Benefits of shingles shot outweigh seniors’ risk of Guillain-Barré syndrome, federal investigators...
By
Alicia Lasek
Nov 11, 2021
Clinicians should be aware of these risks, but weigh them against the benefits of decreasing the likelihood of shingles and its complications, according to investigators from the CDC, FDA and CMS.
Clinical briefs for Monday, July 12
By
Alicia Lasek
Jul 12, 2021
Judge rejects claim that Zostavax caused man’s shingles eight years later … Get blood sugar under control early in type 2 diabetes to cut odds of these poor outcomes: experts … Arthritis drug reduces...
GlaxoSmithKline plans Shingrix push; new RSV shot for elders in works
By
Alicia Lasek
Jun 28, 2021
GSK’s shingles vaccine will get a renewed marketing push following a large drop in sales during the pandemic, and the company is aiming to launch a fast-tracked shot for a common respiratory virus...